Search

everythinglearnresearchcommunity

for

Search:↓

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Upadacitinib effectively treats pyoderma gangrenosum.

Dapagliflozin helps protect heart cells under stress by improving mitochondrial function and reducing cell damage.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Compound 4 is a promising treatment for hair loss with low toxicity.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

A new compound effectively inhibits human 5α-reductase 1.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

The new compound may be a safer alternative to finasteride for prostate protection.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.